Less visceral fat
Targets deep abdominal fat deposits.
Photo 1 of 3
VISCERAL FAT REDUCTION & RECOMPOSITION
The gold-standard GHRH analogue specifically engineered to target deep abdominal fat, tighten the waistline, and support a leaner, stronger physique.
Selectively mobilizes stubborn visceral fat around organs and the midsection that diet alone cannot reach.
Naturally stimulates growth hormone release to keep muscle density tight during a cut.
Pre-filled 32mg multi-dose pen with 8 ultra-comfort 31G needles included.
2.900.000 IDR
Save with a bundle ↗32 mg per pen | Up to 5 weeks of use
In stockBali delivery: 100,000 IDR, free with 3 or more pens. Usually 2–3 hours after confirmation. Delivery details · 7-day returns for product problems
THE SCIENCE BEHIND THE RESULTS
Tesamorelin is a GHRH (Growth Hormone Releasing Hormone) analogue clinically studied to overcome this bottleneck. It triggers natural, pulsatile growth hormone secretion, directly signaling your body to break down intra-abdominal lipid stores while helping to preserve lean muscle.
Targets deep abdominal fat deposits.
Maintain muscle density during a cut.
Support lipid profile and overall health.
3 PATHWAYS TO A DEFINED MIDSECTION
Specifically acts on deep visceral fat deposits, flattening the stomach and sharpening waistline definition.
Elevates circulating IGF-1 levels naturally, preventing muscle wasting during caloric deficits.
Clinically proven to improve triglyceride levels, reduce inflammation markers and support a cleaner metabolic profile.
CLINICAL RESEARCH
Clinical studies show meaningful reduction in visceral adipose tissue (VAT).
Mean percentage change in visceral adipose tissue (VAT). Results from clinical studies in adults with excess abdominal fat. Individual results may vary. Not medical advice.
Your Transformation Timeline
Deeper sleep cycles due to natural GH pulses. Reduced abdominal bloating and improved daily recovery.
Initial visible flattening of the stomach. Muscle tissue feels fuller and denser despite reduced caloric intake.
Noticeable decline in deep belly fat thickness. Core definition and waistline structure become significantly sharper.
Choose a ready-made set with this exact pen format and see the saving on the pair.
Save 300.000 IDRRetatrutide 32 mg + Tesamorelin 32 mg
Compare two different signalling approaches: Retatrutide and the growth-hormone-releasing analogue Tesamorelin.
Save 300.000 IDRCJC-1295 + Ipamorelin 20 mg + Tesamorelin 32 mg
CJC-1295 + Ipamorelin and Tesamorelin. Two distinct products associated with growth-hormone release.
Tesamorelin is a stabilized Growth Hormone Releasing Hormone (GHRH) peptide. It binds to GHRH receptors in the pituitary gland, stimulating the natural, pulsatile release of growth hormone. Unlike generalized fat loss compounds, Tesamorelin is clinically proven to preferentially target Visceral Adipose Tissue (VAT)—the deep, stubborn fat layer surrounding internal abdominal organs.
While Retatrutide drives weight loss through appetite suppression and broad metabolic rate stimulation (GLP-1/GIP/Glucagon), Tesamorelin works via pure GHRH signaling with a specific clinical focus on removing deep abdominal fat. Compared to CJC-1295, Tesamorelin shows superior clinical research in reducing waist circumference and visceral lipid accumulation.
Visceral fat is metabolically active and secretes inflammatory cytokines that impair insulin sensitivity, disrupt cardiovascular health, and mask core muscle definition. By reducing visceral fat, Tesamorelin improves systemic lipid profiles, insulin response, and overall body recomposition.
No. Because Tesamorelin acts as an endogenous secretagogue (prompting your pituitary gland to produce its own growth hormone), it works within your body’s natural physiological pathways without suppressing your endocrine system or causing hormone shutdown.
Improvements in REM sleep quality, overnight tissue recovery, and reduced morning bloat typically occur within the first 1 to 2 weeks. Measurable waistline reduction, firmer abdominal tone, and deep visceral fat loss become visually evident between weeks 4 to 8 of continuous daily administration.
Yes. Tesamorelin stacks exceptionally well with Retatrutide for maximum systemic fat oxidation, or with BPC-157 & TB-500 for accelerated connective tissue repair and joint mobility.
Yes. Our Tesamorelin 32mg comes in a pre-filled precision multi-dose dial pen. There is no need for manual mixing with bacteriostatic water, sterile vial handling, or syringe math—simply select your dose and administer in seconds.
One Tesamorelin 32 mg pen provides up to 5 weeks of use, depending on the amount and frequency prescribed for you. Follow the individual product instructions for storage and use after opening.
Tesamorelin must be kept chilled to maintain active molecular integrity. We deliver all orders across Bali (Canggu, Pererenan, Seminyak, Ubud, Uluwatu) in specialized insulated cold-chain thermal packaging with ice gel packs. Store your pen in the refrigerator between 2°C–8°C upon arrival.